Chemical restraint - how you can support reduction Supported through grant funding from the Australian Government Facilitator: Sarah Nicoll - NDS National Practice Lead, Zero Tolerance Initiative Guest Presenter: Mandy Donley, National Director Behaviour Intervention Support Disability, Mental Health & Aged Care Life Without Barriers
51
Embed
Chemical restraint - how you can support reduction
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Chemical restraint - how you can support reduction
Supported through grant funding from the Australian Government
Facilitator: Sarah Nicoll - NDS National Practice Lead, Zero Tolerance Initiative
Guest Presenter: Mandy Donley, National Director Behaviour Intervention Support
Disability, Mental Health & Aged Care Life Without Barriers
Learning Outcomes
1. Chemical restraint in Australia
2. Understanding medications and side effects
3. Conversations and collaborations
4. Why chemical restraint is used?
5. Q&A
6. Your role – how you can make a difference
Public Hearing 6: Psychotropic medication, behaviour support and behaviours of concern.
"Chemical restraints impair a person’s human rights - a person’s freedom of
movement, liberty, privacy, the right not to be subjected to cruel, inhuman or
degrading treatment and the right to enjoyment of the highest attainable
standard of health without discrimination on the basis of disability.
These are rights recognised by the Convention on the Rights of Persons
with Disabilities (CRPD)."
- Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability. (2020) Public Hearing 6:
Psychotropic medication, behaviour support and behaviours of concern. Opening Address: Kate Eastman SC
Where is the life?
[POLL/ANNOTATE]
Challenging Interesting
Frustrating
Hopeful Powerless
Rewarding – I have supported
reduction of chemical restraint
Not sure – this is new to me
Chemical restraint in Australia URP's for chemical restraint
NDIS Quality and Safeguards Commission(2020). Activity Report: 1 July 2020 to 31 December 2020
Total:269,680
Chemical restraint in Australia
"The inappropriate use of psychotropics is
common and includes overuse of psychotropic
drugs to treat challenging behaviour..."
- Trollor JN, Salomon C, Franklin C. Prescribing psychotropic drugs to adults with an intellectual disability. Aust
Prescriber 2016;39:126-30. Accessed at https://doi.org/10.18773/austprescr.2016.048 on 11/5/2021.
Having the conversation: being aware of medications
Why do people take Antipsychotic medication?
When people are have a psychotic disorder. Such as…
• Schizophrenia
• Schizoaffective disorder
• Bipolar Illness
“Psychotic disorders are characterised by hallucinations, delusions, personality disorganisation, loss of ego boundaries and/or the inability to meet the demands of ordinary life. A person who is psychotic is out of touch with reality”. (www.healthatoz.com)
illness, there is little robust evidence to justify
this practice.”
- Trollor JN, Salomon C, Franklin C. (2016) Prescribing psychotropic drugs to adults with an intellectual disability. Australian Prescriber 39:126-30. Accessed at https://doi.org/10.18773/austprescr.2016.048
NDS is pleased to be able to provide the Behaviour Support Practitioner Workshops
as part of a two-year grant from the NDIS Quality and Safeguards Commission, for
free to the sector.
Supported through grant funding
from the Australian Government
References and Resources Zero Tolerance
Zero Tolerance is an initiative led by NDS in partnership with the disability sector. Zero Tolerance is a way for organisations to understand actions they
can do to prevent and respond to abuse, neglect and violence of people with disability. Zero Tolerance - National Disability Services (nds.org.au)
STOMP Resource: Preparing to visit a doctor to talk about psychotropic medication
Choosing Wisely Australia® National Prescribing Service (N.P.S.) Video :Old v New - Choosing wisely
Victorian Senior Practitioner Reports
D.H.H.S Technical Report: Senior Practitioner, Disability, mental health and medication: Implications for practice and policy
D.H.H.S. Technical Report: Building capacity to assist adult dual disability clients access effective mental health services
Victorian Senior Practitioner Report: Anti-libidinal medication use in people with intellectual disability who sexually offend
D.H.H.S. Technical Report: Building capacity to assist adult dual disability clients access effective mental health servicesVictorian Senior Practitioner Report: Anti-libidinal medication use in people with intellectual disability who sexually offend
NDIS Quality and Safeguards Commission Practice Alerts (please note this is not the full set)
Practice Alert: Medicines associated with swallowing problems
Practice Alert: Dysphagia, safe swallowing and mealtime management
References and ResourcesBowring, D. L., Totsika, V., Hastings, R. P., Toogood, S., & McMahon, M. (2017). Prevalence of psychotropic medication use and association with challenging behaviour in
adults with an intellectual disability. A total population study. Journal of Intellectual Disability Resarch, 61(6), 604–617.Cited in NDIS Quality and Safeguards Commission
Mixit Film S.T.O.M.P (Stop the Over Medication of People with learning disabilities and autism). Accessed at https://youtu.be/PdiLYnHPMrs
National Disability Insurance Scheme (Restrictive Practices and Behaviour Support) Rules 2018
NDIS Quality and Safeguards Commission(2020). NDIS Commission 6-month activity report: July - December 2020.
Accessed at https://www.ndiscommission.gov.au/document/2781
NDIS Quality and Safeguards Commission(2021).Regulated restrictive practices with children and young people with disability: Practice guide | NDIS Quality and
NDIS Quality and Safeguards Commission(2020). Regulated restrictive practices with children and young people with disability: Practice guide | NDIS Quality and